KK2269

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK2269, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KK2269 in Adult Participants With Solid Tumors [Phase 1]